만성질환의 빈도 증가, 노인 인구 증가, 최소침습 수술에 대한 수요 증가, 신장 및 심혈관질환 발생률 증가가 진단용 카테터 시장을 주도하고 있습니다. Verified Market Research의 분석가에 따르면 진단용 카테터 시장은 2024년 약 43억 9,000만 달러의 가치를 지닌 예측치를 넘어 72억 6,000만 달러의 가치에 도달할 것으로 예상됩니다.
진단 정확도와 정밀도가 향상됨에 따라 MRI 지원 카테터, 초음파 유도 카테터와 같은 진단용 카테터에 대한 새로운 기술의 사용이 증가하고 있는 것도 시장을 주도하고 있습니다. 이로 인해 시장은 2024년부터 2031년까지 연평균 6.50%의 CAGR로 성장할 것으로 예상됩니다.
진단용 카테터 시장 정의/개요
진단용 카테터는 다양한 의료 질환을 가시화 및 진단하기 위해 체내에 삽입하는 특수 의료기기입니다. 이 카테터는 혈관조영술과 같은 영상 검사에 사용되며, 영상 검사 중 혈액의 동맥이나 장기의 가시성을 향상시키기 위해 조영제를 주입할 수 있습니다.
또한, 진단용 카테터는 심장질환을 분석하는 순환기내과, 비뇨기과, 소화기 질환을 평가하는 소화기내과, 신경계 질환을 검사하는 신경과 등 의료 분야에서 폭넓게 활용되고 있습니다. 중요한 진단 정보를 제공하는 능력은 현대 의학에서 없어서는 안 될 필수적인 장비가 되었습니다.
심혈관질환의 빈도 증가는 진단용 카테터 시장의 주요 촉진요인입니다. 세계보건기구(WHO)에 따르면 심혈관계 질환은 전 세계 주요 사망 원인으로 매년 1,790만 명이 사망하는 것으로 추정됩니다. 미국심장협회의 2021년 심장병 및 뇌졸중 통계 업데이트에 따르면, 미국 성인의 48%가 심혈관질환을 앓고 있습니다. 이러한 높은 빈도로 인해 정확한 진단과 치료 계획을 보장하기 위해 진단용 카테터를 더 자주 사용해야 합니다.
고령자는 카테터를 통한 진단이 필요한 다양한 질병에 걸리기 쉬워 전 세계 고령화로 인해 진단용 카테터에 대한 수요가 증가하고 있습니다. UN의 World Population Prospects 2019 보고서에 따르면, 2050년까지 6명 중 1명이 65세 이상(16%), 11명 중 1명(9%)에서 증가합니다. 북미와 유럽에서는 이 비율이 2050년까지 4명 중 1명에 달할 것으로 예상됩니다. 이러한 인구통계학적 변화로 인해 카테터를 이용한 진단 및 치료의 필요성이 높아질 것으로 예상됩니다.
또한, 카테터 기술과 그에 수반되는 영상 기술은 지속적으로 발전하여 진단용 카테터의 용도를 확장하고 효능을 향상시키고 있으며, FDA는 2020년에 22개의 새로운 심혈관계 기기를 승인했으며, 그 중 일부는 첨단 카테터 기술을 사용하고 있습니다. Device Innovation Consortium에 따르면, 세계 의료기기 산업은 2021년부터 2028년까지 연평균 5.4% 성장하여 2028년에는 7,198억 달러에 달할 것으로 예측됩니다. 이러한 성장의 한 요인은 다양한 의료 현장에서 널리 사용되고 있는 카테터와 같은 진단 기술의 발전입니다.
진단용 카테터 시장에서는 첨단 장비의 높은 비용이 큰 제약 요인으로 작용하고 있습니다. 고급 진단용 카테터 제작 및 제조에는 고가의 재료와 정교한 설계가 필요하기 때문에 제조 비용이 상승합니다. 그 결과, 최종 소비자 가격이 상승하고, 특히 의료 예산이 제한적인 저개발 국가에서 시장 진입이 제한됩니다.
또한, 진단용 카테터 시장은 기술 부족이라는 문제에 직면해 있습니다. 진단용 카테터를 적절하게 사용하려면 특별한 훈련과 경험이 필요하지만, 모든 의료 환경에서 이러한 훈련을 쉽게 받을 수 있는 것은 아닙니다. 이러한 부족은 특히 농촌 지역이나 의료 혜택이 부족한 지역에서 이러한 장비의 채택을 제한하고 전체 시장 성장에 영향을 미치고 있습니다.
The increasing frequency of chronic ailments, the growing elderly population, the growing desire for less invasive operations, and the rising incidence of kidney and cardiovascular disorders are all driving the diagnostic catheters market. According to the analyst from Verified Market Research, the diagnostic catheter market is estimated to reach a valuation of USD 7.26 Billion over the forecast subjugating around USD 4.39 Billion valued in 2024.
Due to their increased diagnostic accuracy and precision, the market is also being driven by the increasing use of new technologies in diagnostic catheters, such as MRI-compatible and ultrasound-guided catheters. It enables the market to grow at aCAGR of 6.50% from 2024 to 2031.
Diagnostic Catheter Market: Definition/Overview
A diagnostic catheter is a specialized medical device that is placed into the body to help visualize and diagnose various medical diseases. These catheters are employed in imaging procedures like angiography, where they allow for the injection of contrast chemicals to improve the visibility of blood arteries and organs during imaging examinations.
Furthermore, diagnostic catheters have a wide range of applications in medicine, including cardiology for analyzing heart ailments, urology for studying urinary tract concerns, gastroenterology for evaluating digestive illnesses, and neurology for exploring neurological diseases. Their ability to deliver vital diagnostic information makes them indispensable instruments in modern medicine.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
The increasing frequency of cardiovascular illnesses is a major driver of the diagnostic catheter market. According to the World Health Organization (WHO), cardiovascular disease is the leading cause of death worldwide, killing an estimated 17.9 million people each year. According to the American Heart Association's 2021 Heart Disease and Stroke Statistics update, 48% of all adults in the United States suffer from cardiovascular disease. This high frequency needs more frequent use of diagnostic catheters to ensure correct diagnosis and treatment planning.
The global aging population is increasing demand for diagnostic catheters, as older people are more susceptible to different ailments that necessitate catheter-based diagnosis. According to the United Nations World Population Prospects 2019 report, by 2050, one in every six individuals will be beyond the age of 65 (16%), up from one in every eleven (9%). In North America and Europe, this rate is expected to reach one in every four people by 2050. This demographic shift is projected to boost the need for diagnostic treatments involving catheters.
Furthermore, catheter technology and accompanying imaging techniques are constantly evolving, expanding diagnostic catheter uses and improving their efficacy. The FDA authorized 22 novel cardiovascular devices in 2020, several of which use sophisticated catheter technologies. According to the Medical Device Innovation Consortium, the worldwide medical device industry is predicted to increase at a 5.4% CAGR between 2021 and 2028, reaching $719.8 billion by 2028. This growth is being driven in part by advances in diagnostic technology, such as catheters, which are becoming more widely used in a variety of medical operations.
The high cost of advanced equipment is a significant restriction on the diagnostic catheter market. The creation and manufacturing of sophisticated diagnostic catheters require expensive materials and elaborate designs, which raises production costs. This results in increased prices for end consumers, limiting market access, especially in underdeveloped countries where healthcare budgets are constrained.
Furthermore, the diagnostic catheter market faces a problem due to a skills shortage. The proper use of diagnostic catheters necessitates specific training and experience, which are not easily available in all healthcare settings. This shortage restricts the adoption of these devices, particularly in rural or underserved areas, affecting overall market growth.
According to VMR analyst, the diagnostic imaging catheter segment is expected to dominate within the diagnostic catheter market during the forecast period. The increasing frequency of chronic diseases, especially cardiovascular and neurological disorders, necessitates the use of improved diagnostic technologies for optimal therapy. As these disorders become more widespread, the demand for imaging catheters that provide precise and detailed diagnostic information rises, boosting market expansion and reinforcing the segment's dominant position.
The developments in imaging technologies that improve the capabilities of diagnostic imaging catheters are another important driver. Improvements in image resolution, real-time imaging, and integration with other diagnostic modalities have increased the effectiveness and attraction of these catheters to healthcare practitioners. These technical advancements not only improve patient outcomes but also encourage the use of imaging catheters in clinical settings.
Furthermore, the increasing number of imaging and diagnostic centers worldwide is critical to the segment's growth. As healthcare systems extend their diagnostic capacities, there is a greater demand for sophisticated imaging catheters that can match these facilities' requirements. This tendency is especially prominent in emerging nations, where healthcare infrastructure investments are increasing, reinforcing the diagnostic imaging catheter segment's dominance.
The cardiology segment is estimated to hold the largest share of the diagnostic catheter market during the forecast period due to the increasing frequency of cardiovascular disorders. As cardiovascular disease remains the top cause of death worldwide, there is an increasing demand for improved diagnostic technologies. Diagnostic catheters make crucial operations like angiography easier, allowing healthcare providers to precisely detect and treat cardiac problems, which is why they are so often used in cardiology.
Advances in catheter technology have enabled less invasive methods of diagnosing and treating cardiovascular problems, which are preferred by both patients and healthcare practitioners. These treatments often result in faster recovery times and hospital stays, driving up demand for diagnostic catheters in cardiology applications.
Furthermore, technological developments in imaging techniques provide a substantial contribution to the cardiology segment's growth. Enhancements to diagnostic catheter imaging capabilities improve the accuracy and effectiveness of cardiovascular examinations. These innovations not only improve diagnosis and treatment planning but also raise the overall efficiency of cardiovascular care, maintaining the cardiology segment's dominant position in the diagnostic catheter market.
North America is estimated to dominate the diagnostic catheter market during the forecast period. North America, particularly the United States, has a high burden of cardiovascular illness, which drives demand for diagnostic catheters. According to the American Heart Association's 2021 Heart Disease and Stroke Statistics update, heart disease kills approximately 655,000 Americans each year, accounting for one out of every four fatalities. According to the Centers for Disease Control and Prevention (CDC), coronary heart disease is the most frequent type of heart disease, accounting for 365,914 deaths in 2017. Because of the high frequency of cardiovascular disorders, diagnostic catheters are used regularly to ensure appropriate diagnosis and treatment.
Furthermore, North America's advanced healthcare infrastructure and significant healthcare spending help to drive the diagnostic catheter market in this region. According to the Centers for Medicare and Medicaid Services, healthcare spending in the United States increased by 9.7% in 2020 to $4.1 trillion, or $12,530 per person. Health spending made up 19.7% of the nation's GDP. This high healthcare spending allows for higher use of new medical technologies, such as sophisticated diagnostic catheters.
The Asia Pacific region is estimated to exhibit the highest growth within the market during the forecast period. The Asia Pacific region's population is rapidly aging, creating the need for diagnostic catheters. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the region's elder population (aged 65 and more) is predicted to more than double from 535 million in 2015 to around 1.3 billion by 2050. This demographic transition coincides with an increase in the prevalence of chronic diseases. According to the World Health Organization, cardiovascular illnesses cause 31% of all fatalities in the Western Pacific Region, accounting for an estimated 6.7 million deaths each year. The increasing illness load is driving the demand for catheter-based diagnostic catheters.
Furthermore, the Asia Pacific region is experiencing tremendous increases in healthcare infrastructure and investment, which is pushing the adoption of modern medical technologies such as diagnostic catheters. According to the World Bank, health expenditure as a proportion of GDP in East Asia and the Pacific rose from 6.4% in 2010 to 7.1% in 2018. In South Asia, it increased from 3.5% to 3.9% over the same period. The Asian Development Bank predicts that healthcare spending in Asia will reach $2.4 trillion by 2030, a 250% increase over 2015 figures. This increasing investment allows healthcare facilities to obtain and use more sophisticated diagnostic technologies, such as improved catheter systems.
The diagnostic catheter market is competitive due to rapid technical improvements and a focus on product differentiation. Companies are investing extensively in R&D to innovate and improve diagnostic catheter performance, including imaging enhancements and the development of customized catheters for a variety of medical purposes.
Some of the prominent players operating in the diagnostic catheter market include:
Medtronic plc
Boston Scientific Corporation
Abbott
Johnson & Johnson
Koninklijke Philips N.V.
Terumo Corporation
Bard, Inc.
Edwards Lifesciences Corporation
Braun Melsungen AG
Cardinal Health, Inc.
Diagnostic Catheter Market Latest Developments:
In September 2022, Philips introduced the Verisight Pro, a real-time 3D intracardiac echocardiography system. At Baptist Health's Miami Cardiac & Vascular Institute in Florida, the ICE catheter was effectively used to treat patients with structural heart disease during minimally invasive image-guided treatments.